BioNeutra Global Stock

BioNeutra Global ROE

The Return on Equity (ROE) of BioNeutra Global (BGA.V) as of Aug 23, 2026 is 34.03 %. In the previous year, Return on Equity (ROE) was 77.79 % — a change of -56.26% (lower).

ROE

34.03 %

YoY

-56.26%

Last updated:

In 2026, BioNeutra Global's return on equity (ROE) was 34.03 %, a -56.26% increase from the 77.79 % ROE in the previous year.

The BioNeutra Global ROE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROE
Date
ROE
Jan 1, 2016
6.84 CAD
Jan 1, 2017
-8.32 CAD
Jan 1, 2018
17.18 CAD
Jan 1, 2019
-261.83 CAD
Jan 1, 2020
-528.89 CAD
Jan 1, 2021
273.68 CAD
Jan 1, 2022
77.79 CAD
Jan 1, 2023
34.03 CAD
The BioNeutra Global ROE history
YEARROEYoY
34.03 %-56.26%
77.79 %-71.58%
273.68 %-151.75%
-528.89 %+102.00%
-261.83 %-1,623.77%
17.18 %-306.58%
-8.32 %-221.61%
6.84 %+478.70%
1.18 %-97.05%
40.03 %—
Access this data via the Eulerpool API
Get Free API Key

BioNeutra Global Stock analysis

What does BioNeutra Global do? BioNeutra Global is one of the most popular companies on Eulerpool.

ROE Details

Decoding BioNeutra Global's Return on Equity (ROE)

BioNeutra Global's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing BioNeutra Global's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

BioNeutra Global's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in BioNeutra Global’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about BioNeutra Global stock

Return on Equity (ROE) of BioNeutra Global is 34.03 % in 2026.

Return on Equity (ROE) of BioNeutra Global changed from 77.79 % to 34.03 %, representing a -56.26% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) BioNeutra Global since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s BioNeutra Global with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API
Get Free API Key

Profitability — BioNeutra Global

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — BioNeutra Global